✦ LIBER ✦

Bone marrow involvement in young patients with non-Hodgkin's lymphoma: The importance of multiple bone marrow samples for accurate staging

✍ Scribed by Haddy, Theresa B. ;Parker, Robert I. ;Magrath, Ian T.

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 582 KB
Volume: 17
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950170512

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone marrow staging in patients with non

Bone marrow staging in patients with non-hodgkin's lymphoma : Is flow cytometry a useful test?

✍ Michael J. Naughton; Jay L. Hess; Mary M. Zutter; Nancy L. Bartlett 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 3 views

BACKGROUND. Flow cytometric analysis of bone marrow often is used as an adjunct

Bone marrow staging of patients with non

Bone marrow staging of patients with non-Hodgkin's lymphoma : Is flow cytometry a useful test?

✍ Iwona Auer; Joanne Luider 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 3 views

Is Flow Cytometry a Useful Test? R epresenting a busy flow cytometry laboratory with an annual workload of approximately 1400 acute leukemia and malignant lymphoma cases, we read the article by Naughton et al. 1 with considerable interest. The authors concluded that "flow cytometry of bone marrow as

LSA2–L2 protocol treatment of stage IV n

LSA2–L2 protocol treatment of stage IV non-hodgkin's lymphoma in children with partial and extensive bone marrow involvement

✍ Luz Duque-Hammershaimb; Norma Wollner; Denis R. Miller 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 2 views

Heterogeneity among the non-Hodgkin's ly

Heterogeneity among the non-Hodgkin's lymphomas. implications for autologous bone marrow transplantation with in vitro Purging using monoclonal antibodies

✍ Jane N. Winter; Robert J. Marder; Binita Mankad; Alan L. Epstein 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 860 KB

To investigate the possible implications of heterogeneity among the non-Hodgkin's lymphomas for bone marrow purging using complement-fixing monoclonal antibodies to lymphoma-associated antigens, a panel of large cell lymphoma cell lines of diverse phenotypes was treated with monoclonal antibodies DL